Form D · Biotechnology
MiLaboratories Inc.
Wilmington, DE · CIK 0001910574
Offering snapshot reported Feb 17, 2022 · SEC filing
- Reported sold
- $2.36M Offering amount: $2.36M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jan 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2022 | Initial | $2,359,875 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-434028
Source: Form D, filed Feb 17, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dmitry Bolotin | Director, Executive |
| Dmitry Chudakov | Director, Executive |
| Alexey Nechaev | Executive |
| Stanislav Poslavskii | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
251 Little Falls Drive
Wilmington, DE, 19808
Wilmington, DE, 19808